(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -521.73%-57.4K | 92.76%-50.17K | 87.25%-22.03K | 96.60%-14.88K | 90.16%-4.03K | 77.71%-9.23K | -693.35K | -172.76K | -438.21K | -40.95K |
Net income from continuing operations | 88.45%-16.22K | 48.81%-388.57K | 86.31%-44.85K | 70.73%-80.59K | -30.01%-122.7K | -127.77%-140.43K | ---759.08K | ---327.69K | ---275.36K | ---94.38K |
Operating gains losses | ---- | --11.5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Unrealized gains and losses of investment securities | ---60K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Remuneration paid in stock | ---- | --0 | ---- | ---- | ---- | ---- | --144.5K | ---- | ---- | ---- |
Change In working capital | -85.66%18.81K | 515.02%326.9K | 8.56%11.33K | 140.35%65.71K | 122.14%118.67K | 548.61%131.19K | ---78.77K | --10.43K | ---162.85K | --53.42K |
-Change in receivables | 7.23%-2.14K | ---5.82K | -107.17%-872 | 92.26%-942 | ---1.7K | ---2.31K | --0 | --12.16K | ---12.16K | --0 |
-Change in prepaid assets | --0 | 200.00%202.17K | --0 | 116.87%47.04K | --69.69K | --85.44K | ---202.17K | --76.6K | ---278.77K | --0 |
-Change in payables and accrued expense | -56.39%20.96K | 5.79%130.55K | 115.57%12.2K | -84.69%19.61K | -5.14%50.68K | 137.61%48.06K | --123.41K | ---78.33K | --128.09K | --53.42K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -521.73%-57.4K | 92.76%-50.17K | 87.25%-22.03K | 96.60%-14.88K | 90.16%-4.03K | 77.71%-9.23K | ---693.35K | ---172.76K | ---438.21K | ---40.95K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 105.67%397 | 102.57%3K | 10K | 0 | 0 | 82.51%-7K | -116.52K | 0 | -71.59K | -4.91K |
Net PPE purchase and sale | --0 | 102.57%3K | --10K | --0 | --0 | 82.51%-7K | ---116.52K | --0 | ---71.59K | ---4.91K |
Net business purchase and sale | --397 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 105.67%397 | 102.57%3K | --10K | --0 | --0 | 82.51%-7K | ---116.52K | --0 | ---71.59K | ---4.91K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 525.00%62.5K | -89.65%44.25K | 18.5K | 15.75K | 0 | -93.13%10K | 427.46K | 0 | 0 | 282K |
Net common stock issuance | --62.5K | --0 | --0 | --0 | --0 | --0 | --429.49K | --0 | --0 | --282K |
Net other financing activities | ---- | 2,279.80%44.25K | --18.5K | --15.75K | --0 | 592.61%10K | ---2.03K | --0 | --0 | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 525.00%62.5K | -89.65%44.25K | --18.5K | --15.75K | --0 | -93.13%10K | --427.46K | --0 | --0 | --282K |
Net cash flow | ||||||||||
Beginning cash position | -28.98%7.15K | -97.44%10.06K | -99.63%675 | -100.03%-197 | -99.23%3.83K | -97.44%10.06K | --392.48K | --182.82K | --692.63K | --496.49K |
Current changes in cash | 188.13%5.49K | 99.24%-2.92K | 103.75%6.47K | 100.17%872 | -102.05%-4.03K | -105.99%-6.23K | ---382.41K | ---172.76K | ---509.8K | --196.14K |
End cash Position | 229.94%12.64K | -28.98%7.15K | -28.98%7.15K | -99.63%675 | -100.03%-197 | -99.23%3.83K | --10.06K | --10.06K | --182.82K | --692.63K |
Free cash from | -253.63%-57.4K | 92.94%-57.17K | 87.25%-22.03K | 97.08%-14.88K | 91.22%-4.03K | 80.07%-16.23K | ---809.87K | ---172.76K | ---509.8K | ---45.86K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data